| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
|
Plummer, Ruth
|
|
2012
|
71 |
1 |
p. 93-101
|
artikel
|
| 2 |
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors
|
Gordon, Michael S.
|
|
2012
|
71 |
1 |
p. 21-27
|
artikel
|
| 3 |
Assessing the in vivo efficacy of biologic antiangiogenic therapies
|
Wilson, Peter M.
|
|
2012
|
71 |
1 |
p. 1-12
|
artikel
|
| 4 |
Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis
|
Chen, Jian
|
|
2012
|
71 |
1 |
p. 265-272
|
artikel
|
| 5 |
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response
|
Litviakov, Nicolay V.
|
|
2012
|
71 |
1 |
p. 153-163
|
artikel
|
| 6 |
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug–drug interaction potential
|
LoRusso, Patricia M.
|
|
2012
|
71 |
1 |
p. 193-202
|
artikel
|
| 7 |
Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor
|
Cui, Yuehong
|
|
2012
|
71 |
1 |
p. 145-152
|
artikel
|
| 8 |
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
|
Park, Mi Sung
|
|
2012
|
71 |
1 |
p. 165-173
|
artikel
|
| 9 |
Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer
|
Chi, K. N.
|
|
2012
|
71 |
1 |
p. 237-244
|
artikel
|
| 10 |
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers
|
Yin, Ophelia Q. P.
|
|
2012
|
71 |
1 |
p. 219-226
|
artikel
|
| 11 |
Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients
|
Miyahara, T.
|
|
2012
|
71 |
1 |
p. 175-182
|
artikel
|
| 12 |
Erlotinib in patients with advanced lung squamous cell carcinoma
|
Chiang, Chi-Lu
|
|
2012
|
71 |
1 |
p. 203-208
|
artikel
|
| 13 |
Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects
|
Abbas, Richat
|
|
2012
|
71 |
1 |
p. 123-132
|
artikel
|
| 14 |
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines
|
Parise, Robert A.
|
|
2012
|
71 |
1 |
p. 73-83
|
artikel
|
| 15 |
Hemodialysis no reason to withhold everolimus
|
Rooijen, J. M. van
|
|
2012
|
71 |
1 |
p. 273-274
|
artikel
|
| 16 |
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
|
Ott, Patrick A.
|
|
2012
|
71 |
1 |
p. 183-191
|
artikel
|
| 17 |
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial
|
Ott, Patrick A.
|
|
|
71 |
1 |
p. 183-191
|
artikel
|
| 18 |
Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia
|
Hsyu, Poe-Hirr
|
|
2012
|
71 |
1 |
p. 209-218
|
artikel
|
| 19 |
Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors
|
Nemunaitis, John
|
|
2012
|
71 |
1 |
p. 35-41
|
artikel
|
| 20 |
Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer
|
Chu, B. F.
|
|
2012
|
71 |
1 |
p. 115-121
|
artikel
|
| 21 |
Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer
|
Kusaba, Hitoshi
|
|
2012
|
71 |
1 |
p. 29-34
|
artikel
|
| 22 |
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023
|
Kerklaan, Bojana Milojkovic
|
|
2012
|
71 |
1 |
p. 53-62
|
artikel
|
| 23 |
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
|
Esteva, Francisco J.
|
|
2012
|
71 |
1 |
p. 63-72
|
artikel
|
| 24 |
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer
|
Esteva, Francisco J.
|
|
|
71 |
1 |
p. 63-72
|
artikel
|
| 25 |
Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors
|
Doi, Toshihiko
|
|
2012
|
71 |
1 |
p. 227-235
|
artikel
|
| 26 |
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts
|
Choo, Edna F.
|
|
2012
|
71 |
1 |
p. 133-143
|
artikel
|
| 27 |
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial
|
Pliarchopoulou, K.
|
|
2012
|
71 |
1 |
p. 245-255
|
artikel
|
| 28 |
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer
|
Kartal Yandım, Melis
|
|
2012
|
71 |
1 |
p. 13-20
|
artikel
|
| 29 |
Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation
|
Kang, Yoon-Koo
|
|
2012
|
71 |
1 |
p. 43-51
|
artikel
|
| 30 |
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer
|
Takahara, Naminatsu
|
|
2012
|
71 |
1 |
p. 85-92
|
artikel
|
| 31 |
Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
|
Zhang, Jian
|
|
2012
|
71 |
1 |
p. 103-113
|
artikel
|
| 32 |
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study
|
Rosati, Gerardo
|
|
2012
|
71 |
1 |
p. 257-264
|
artikel
|
Tijdschrift beschrijving